A recent study by Yale researchers found that Borrelia burgdorferi, the causative agent of Lyme disease, exhibits a unique pattern of cell growth, elongating through discrete “hot zones” of cell wall synthesis that mark where daughter cells will divide. This discovery could help yield new, targeted therapies for Lyme disease.
Tag "Public Health"
The Yale Cancer Biology Institute on West Campus is now the nexus of a new initiative geared towards understanding the dynamic changes in cell behavior that characterize cancer. The Institute, together with its collaborators, was the recipient of a 9.5 million dollar grant from the NIH; the funding may pave the way for more advanced therapies that target metastatic cells.
A project that began in a Yale classroom has since grown into a thriving and ambitious startup that promises to revolutionize the nanotechnology industry and change how we test potentially contaminated water. Monika Weber, an Electrical Engineering Ph.D. candidate, founded
For many years, gene editing has been hailed as the future of medicine. As the genetic basis of disease becomes clearer, researchers continue to discover more ways to alter the genome and prevent or cure diseases. Recently, a new gene
In the early 1950s, manufacturers began to use the compound bisphenol A—more colloquially known as BPA—as a strengthening agent in commercial plastics. It wasn’t until forty years later that researchers began to suspect that synthetic chemicals like BPA could disrupt
Yale professor of medicine Lynn Fiellin works through the Yale play2PREVENT Lab to develop video games for children and teens that aim to prevent health issues such as HIV, smoking, and drug abuse.
Tackling Inflammation at its Genetic Roots: Applying Personalized Medicine to Autoimmunity and Cancer
Yale researchers, led by professor of medicine Richard Bucala, have discovered that the transcription factor, ICBP90, governs the disease-causing aspect of a key inflammatory gene. This discovery has spurred new drug development efforts for patients of inflammatory and autoimmune diseases as well as cancer.
A recent study led by Yale researchers indicates that the hormone FGF21 may help protect against the collapse of the immune system with age by preventing the degradation of the thymus. This discovery may offer a promising treatment for improving immunity in the elderly, as well as for helping cancer patients following bone marrow transplants.
With the support from a new grant from the Bill & Melinda Gates Foundation, Virginia Pitzer will develop models on how best to use typhoid vaccines in developing countries.
A team of Yale students has developed an electronic method to store a child’s vaccination records using wearable computer chip technology. The project was designed for use in rural Indian communities without Internet access.